subscribe
 

Investment in R&D and cleanroom expertise

6th September 2017

Posted By Paul Boughton


Cleanroom and laboratory design and construction specialist, Boulting Environmental Services (BES) has completed the construction phase of a £13 million project for global pharmaceutical business and world leader in the treatment of opioid addiction, Indivior.

The new research and development (R&D) facility will be used to test and manufacture a non-addictive alternative to methadone, in order to improve patient experience on a global scale.

Boulting Environmental Services was the principal designer and principal contractor for the project, carrying out a complete turnkey package that included groundwork, piling, shell construction and the internal specialist architectural fit out of cleanrooms and laboratories.

The two-storey cGMP facility provides 5,000 square metres of ISO7 and ISO8 product development cleanrooms and laboratories, along with highly specified offices, meeting rooms and a restaurant for staff.

Due to the nature of the facility, a full inspection from the Home Office was required after construction. The auditor not only gave the building approval, but referred to it as state-of-the-art — a testament to the quality of work that Boulting Environmental Services carried out on the site.





Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe